Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Valo Therapeutics Oy
OY
Active
Y-tunnus 2768695-4
Viikinkaari 6, 00790
Helsinki
Research and experimental development on natural sciences and engineering
· NACE 7210
Est. 2016 · 9 years old
14 employees
Share
Finland
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Valo Therapeutics Oy
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (2)
LK
Lukasz Kuryk
Confidential Clerk
Confidential Clerk
2026
MO
Marcella Origgi
Chief Executive Officer
Chief Executive Officer
2025
Former (5)
TJ
Terhi Johanna Mäkinen
Audit
Audit
2017 – 2023
SA
Sari Anneli Pesonen
Chief Executive Officer
Chief Executive Officer
2024 – 2025
PG
Paul Grant Higham
Chief Executive Officer
Chief Executive Officer
2020 – 2024
ML
Michael Lewis Stein
Chief Executive Officer
Chief Executive Officer
2017 – 2020
CM
Charlotta Maria Backman
Confidential Clerk
Confidential Clerk
2018 – 2026
Board of directors
Non-executive oversight
Name
Role
Member since
Current (5)
CF
Caterina Flick
Board of Directors
2025
AP
Andrew Peter Dean
Board of Directors
2024
GR
Giovanni Rizzo
Board of Directors
2025
TY
Tee Yen Ng
Board of Directors
2026
PA
Paul Anthony Porter
Board of Directors
2017
Former (6)
HM
Heikki Matti Kalervo Hautsalo
Board of Directors
2024 – 2025
DA
David Ayers Hinton
Board of Directors
2021 – 2024
MM
Milla Maria Koistinaho
Board of Directors
2017 – 2023
VC
Vincenzo Cerullo
Board of Directors
2017 – 2021
MZ
Mai-Britt Zocca
Board of Directors
2020 – 2024
AJ
Anthony John Giovinazzo
Board of Directors
2023 – 2024
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Valo Therapeutics Oy
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network